Elite Pharmaceuticals Inc /Nv/
ELTP
Revenue
18.80M
▲854.00k▲4.76%
3 Months ChangeAssets
87.85M
▲4.19M▲5.01%
3 Months ChangeLiabilities
29.60M
▲3.52M▲13.52%
3 Months ChangeFree Cash Flow
2.37M
▲3.02M▲462.81%
24 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-10
Form 8-K
ID: 0001493152-24-040752
2024-10-07
Form 8-K
ID: 0001493152-24-040288
2024-08-27
Form 8-K
ID: 0001493152-24-034019
2024-08-14
Form 8-K
ID: 0001493152-24-032412
2024-08-14
Form 10-Q
ID: 0001493152-24-032154
2024-07-01
Form 8-K
ID: 0001493152-24-025848
2024-06-21
Form 8-K
ID: 0001493152-24-024720
2024-06-05
Form 8-K
ID: 0001493152-24-022732
2024-05-20
Form 8-K
ID: 0001493152-24-020707
2024-02-14
Form 8-K
ID: 0001493152-24-006722